Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Regimens for HIV-Infected Subjects After Induction Therapy
NCT00001084Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Continued ZDV/3TC/IDV, ZDV/3TC and IDV (3 arms). Primary endpoint: Proportion of patients who sustain suppression of plasma HIV RNA to undetectable levels at 18 months. Status: completed.
02
Drugs
zidovudinelamivudineindinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00001084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001084.